Histogen Financial Statements From 2010 to 2024

HSTO Stock  USD 0.02  0.01  25.65%   
Histogen financial statements provide useful quarterly and yearly information to potential Histogen investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Histogen financial statements helps investors assess Histogen's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Histogen's valuation are summarized below:
Gross Profit
-1.3 M
Market Capitalization
85.4 K
Enterprise Value Revenue
2.8893
Revenue
19 K
Earnings Share
(2.81)
We have found one hundred twenty available fundamental trends for Histogen, which can be analyzed and compared to other ratios and to its competitors. Self-guided Investors are advised to confirm Histogen's regular fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself down the road. As of the 23rd of November 2024, Market Cap is likely to drop to about 2.9 M. In addition to that, Enterprise Value is likely to grow to about (5.3 M)

Histogen Total Revenue

18,050

Check Histogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Histogen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 169.1 K, Interest Expense of 0.0 or Selling General Administrative of 8.9 M, as well as many indicators such as Price To Sales Ratio of 0.77, Dividend Yield of 0.0 or PTB Ratio of 0.2. Histogen financial statements analysis is a perfect complement when working with Histogen Valuation or Volatility modules.
  
Check out the analysis of Histogen Correlation against competitors.
To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.

Histogen Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets33 M17.2 M42.2 M
Slightly volatile
Short and Long Term Debt Total3.9 M5.3 MM
Slightly volatile
Other Current Liabilities362.5 K381.6 K3.1 M
Very volatile
Total Current Liabilities1.1 M1.1 M7.7 M
Very volatile
Property Plant And Equipment Net6.2 M5.9 M1.9 M
Slightly volatile
Accounts Payable326.6 K343.8 KM
Slightly volatile
Cash12.3 M10.9 M12.6 M
Pretty Stable
Non Current Assets Total6.8 M6.5 M2.6 M
Slightly volatile
Non Currrent Assets Other1.1 M601.5 K779.1 K
Slightly volatile
Cash And Short Term Investments10.7 M11.3 M36.9 M
Slightly volatile
Common Stock Total Equity1.1 K1.1 K1.8 K
Pretty Stable
Common Stock Shares Outstanding4.5 M2.9 M5.7 M
Slightly volatile
Short Term Investments342 K360 K24.5 M
Slightly volatile
Liabilities And Stockholders Equity33 M17.2 M42.2 M
Slightly volatile
Non Current Liabilities Total4.9 M5.1 MM
Pretty Stable
Other Current Assets1.4 M975.2 K1.1 M
Slightly volatile
Total Liabilities4.9 M5.1 M15.6 M
Very volatile
Property Plant And Equipment Gross6.2 M5.9 M1.9 M
Slightly volatile
Total Current Assets11.5 M12.1 M38.7 M
Slightly volatile
Common StockK5.8 K2.7 K
Slightly volatile
Other Assets571.4 K601.5 K1.1 M
Very volatile
Long Term Debt315.5 K332.1 K2.3 M
Pretty Stable
Long Term Debt Total7.8 M15.1 M8.1 M
Slightly volatile
Capital Surpluse210.4 M250.9 M190 M
Slightly volatile
Property Plant Equipment6.2 M5.9 MM
Slightly volatile
Current Deferred Revenue16.2 K17.1 K16 M
Slightly volatile
Net Receivables84.6 K89.1 K1.7 M
Slightly volatile
Other Liabilities67.5 K71.1 K1.3 M
Slightly volatile
Inventory716.6 K460 K543 K
Pretty Stable
Capital Lease ObligationsM5.3 M1.7 M
Slightly volatile
Net Working Capital10.5 M14.1 M4.8 M
Slightly volatile
Short Term Debt173.2 K284.1 K140.9 K
Slightly volatile
Deferred Long Term Liabilities566.4 K637.2 K693.8 K
Slightly volatile
Short and Long Term Debt77.6 K87.3 K95.1 K
Slightly volatile
Non Current Liabilities Other14.4 K12.6 K19.8 K
Slightly volatile

Histogen Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative8.9 M8.8 M7.5 M
Slightly volatile
Other Operating Expenses20 M13 M21.2 M
Very volatile
Research Development3.1 M3.3 M12.9 M
Very volatile
Total Operating Expenses18.8 M12.1 M20.8 M
Very volatile
Interest Income685.9 K653.2 K305.7 K
Slightly volatile
Total Revenue18.1 K19 K6.2 M
Very volatile
Gross Profit3.2 M3.4 M6.4 M
Pretty Stable
Cost Of Revenue119.7 K126 K1.6 M
Slightly volatile
Reconciled Depreciation136 K138 K137.3 K
Slightly volatile

Histogen Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation506.4 K533 K1.4 M
Very volatile
Begin Period Cash Flow15.2 M15 M12 M
Pretty Stable
End Period Cash Flow4.6 M4.9 M11.1 M
Very volatile
Change To Netincome590 K621 K1.4 M
Very volatile
Dividends Paid390.4 K439.2 K478.2 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.770.8171.637
Slightly volatile
Days Sales Outstanding10.4711.03542
Slightly volatile
Average Payables8.6 M8.2 M5.4 M
Slightly volatile
Stock Based Compensation To Revenue0.150.13322.0762
Slightly volatile
Inventory Turnover0.140.1514.1822
Slightly volatile
Days Of Inventory On Hand2.7 K2.6 K754
Slightly volatile
Sales General And Administrative To Revenue4.442.877.5452
Slightly volatile
Research And Ddevelopement To Revenue1.461.5313.144
Slightly volatile
Capex To Revenue0.05670.05160.0952
Slightly volatile
Cash Per Share4.264.48103
Very volatile
Net Debt To EBITDA0.50.640.5386
Pretty Stable
Current Ratio7.8412.5410.1527
Slightly volatile
Receivables Turnover35.4243.7829.8445
Slightly volatile
Graham Number19.9621.01196
Very volatile
Debt To Equity0.0880.05340.0725
Pretty Stable
Capex Per Share0.05750.06050.152
Pretty Stable
Revenue Per Share1.281.3536.404
Very volatile
Interest Debt Per Share3.0E-44.0E-47.5999
Very volatile
Debt To Assets0.03630.02790.0342
Pretty Stable
Long Term Debt To Capitalization0.07050.04040.0737
Very volatile
Total Debt To Capitalization0.06610.05040.0594
Pretty Stable
Debt Equity Ratio0.0880.05340.0725
Pretty Stable
Quick Ratio7.7112.1710.0361
Slightly volatile
Net Income Per E B T1.361.151.4772
Slightly volatile
Cash Ratio9.278.833.6189
Slightly volatile
Days Of Inventory Outstanding2.7 K2.6 K754
Slightly volatile
Days Of Sales Outstanding10.4711.03542
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.820.920.9945
Slightly volatile
Fixed Asset Turnover0.810.8531.1851
Very volatile
Debt Ratio0.03630.02790.0342
Pretty Stable
Price Sales Ratio0.770.8171.637
Slightly volatile
Asset Turnover0.220.230.3899
Pretty Stable
Gross Profit Margin0.90.870.8953
Slightly volatile
Operating Cycle2.8 K2.6 K1.3 K
Slightly volatile

Histogen Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.9 M3.1 M6.4 M
Slightly volatile

Histogen Fundamental Market Drivers

Cash And Short Term Investments12.5 M

Histogen Upcoming Events

9th of November 2023
Upcoming Quarterly Report
View
30th of September 2023
Next Fiscal Quarter End
View
30th of June 2023
Last Quarter Report
View

About Histogen Financial Statements

Histogen investors utilize fundamental indicators, such as revenue or net income, to predict how Histogen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue17.1 K16.2 K
Total Revenue19 K18.1 K
Cost Of Revenue126 K119.7 K
Stock Based Compensation To Revenue 0.13  0.15 
Sales General And Administrative To Revenue 2.87  4.44 
Research And Ddevelopement To Revenue 1.53  1.46 
Capex To Revenue 0.05  0.06 
Revenue Per Share 1.35  1.28 
Ebit Per Revenue(2.54)(2.67)

Pair Trading with Histogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Histogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will appreciate offsetting losses from the drop in the long position's value.

Moving against Histogen Stock

  0.69RNXT RenovoRxPairCorr
  0.51MDGL Madrigal PharmaceuticalsPairCorr
The ability to find closely correlated positions to Histogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Histogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Histogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Histogen to buy it.
The correlation of Histogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Histogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Histogen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Histogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Histogen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Histogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Histogen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Histogen Stock:
Check out the analysis of Histogen Correlation against competitors.
To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Histogen. If investors know Histogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Histogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.81)
Revenue Per Share
0.004
Return On Assets
(0.54)
Return On Equity
(1.20)
The market value of Histogen is measured differently than its book value, which is the value of Histogen that is recorded on the company's balance sheet. Investors also form their own opinion of Histogen's value that differs from its market value or its book value, called intrinsic value, which is Histogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Histogen's market value can be influenced by many factors that don't directly affect Histogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Histogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Histogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Histogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.